hearing_members

Committee members present at hearings.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

54 rows where package_id = "CHRG-108hhrg96099" sorted by name

✎ View and edit SQL

This data as json, CSV (advanced)

role 1

Link package_id name ▼ role bioguide_id
CHRG-108hhrg96099,Albert Russell Wynn FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Albert Russell Wynn committee member W000784
CHRG-108hhrg96099,Anna G. Eshoo FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Anna G. Eshoo committee member E000215
CHRG-108hhrg96099,Barbara Cubin FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Barbara Cubin committee member C000962
CHRG-108hhrg96099,Bart Gordon FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Bart Gordon committee member  
CHRG-108hhrg96099,Bart Stupak FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Bart Stupak committee member S001045
CHRG-108hhrg96099,Bobby L. Rush FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Bobby L. Rush committee member R000515
CHRG-108hhrg96099,Charles A. Gonzalez FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Charles A. Gonzalez committee member G000544
CHRG-108hhrg96099,Charles F. Bass FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Charles F. Bass committee member B000220
CHRG-108hhrg96099,Charles W. Norwood FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Charles W. Norwood committee member N000159
CHRG-108hhrg96099,Christopher Cox FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Christopher Cox committee member  
CHRG-108hhrg96099,Christopher John FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Christopher John committee member J000110
CHRG-108hhrg96099,Cliff Stearns FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Cliff Stearns committee member S000822
CHRG-108hhrg96099,Darrell E. Issa FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Darrell E. Issa committee member I000056
CHRG-108hhrg96099,Diana DeGette FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Diana DeGette committee member D000197
CHRG-108hhrg96099,Ed Whitfield FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Ed Whitfield committee member W000413
CHRG-108hhrg96099,Edolphus Towns FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Edolphus Towns committee member T000326
CHRG-108hhrg96099,Edward J. Markey FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Edward J. Markey committee member M000133
CHRG-108hhrg96099,Eliot L. Engel FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Eliot L. Engel committee member E000179
CHRG-108hhrg96099,Frank Pallone, Jr. FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Frank Pallone, Jr. committee member P000034
CHRG-108hhrg96099,Fred Upton FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Fred Upton committee member U000031
CHRG-108hhrg96099,Gene Green FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Gene Green committee member G000410
CHRG-108hhrg96099,George Radanovich FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 George Radanovich committee member R000004
CHRG-108hhrg96099,Greg Walden FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Greg Walden committee member W000791
CHRG-108hhrg96099,Heather Wilson FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Heather Wilson committee member W000789
CHRG-108hhrg96099,Henry A. Waxman FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Henry A. Waxman committee member W000215
CHRG-108hhrg96099,Hilda L. Solis FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Hilda L. Solis committee member S001153
CHRG-108hhrg96099,James C. Greenwood FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 James C. Greenwood committee member G000439
CHRG-108hhrg96099,Janice D. Schakowsky FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Janice D. Schakowsky committee member S001145
CHRG-108hhrg96099,Jim Davis FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Jim Davis committee member  
CHRG-108hhrg96099,Joe Barton FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Joe Barton committee member B000213
CHRG-108hhrg96099,John B. Shadegg FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 John B. Shadegg committee member S000275
CHRG-108hhrg96099,John D. Dingell FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 John D. Dingell committee member D000355
CHRG-108hhrg96099,John Shimkus FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 John Shimkus committee member S000364
CHRG-108hhrg96099,John Sullivan FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 John Sullivan committee member S001055
CHRG-108hhrg96099,Joseph R. Pitts FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Joseph R. Pitts committee member P000373
CHRG-108hhrg96099,Karen McCarthy FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Karen McCarthy committee member M000316
CHRG-108hhrg96099,Lee Terry FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Lee Terry committee member T000459
CHRG-108hhrg96099,Lois Capps FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Lois Capps committee member C001036
CHRG-108hhrg96099,Mary Bono Mack FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Mary Bono Mack committee member B001228
CHRG-108hhrg96099,Michael Bilirakis FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Michael Bilirakis committee member B000463
CHRG-108hhrg96099,Michael F. Doyle FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Michael F. Doyle committee member D000482
CHRG-108hhrg96099,Mike Ferguson FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Mike Ferguson committee member  
CHRG-108hhrg96099,Mike Rogers FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Mike Rogers committee member R000575
CHRG-108hhrg96099,Nathan Deal FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Nathan Deal committee member D000168
CHRG-108hhrg96099,Paul E. Gillmor FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Paul E. Gillmor committee member G000210
CHRG-108hhrg96099,Peter Deutsch FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Peter Deutsch committee member D000275
CHRG-108hhrg96099,Ralph M. Hall FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Ralph M. Hall committee member H000067
CHRG-108hhrg96099,Richard Burr FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Richard Burr committee member B001135
CHRG-108hhrg96099,Rick Boucher FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Rick Boucher committee member  
CHRG-108hhrg96099,Sherrod Brown FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Sherrod Brown committee member B000944
CHRG-108hhrg96099,Steve Buyer FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Steve Buyer committee member  
CHRG-108hhrg96099,Ted Strickland FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Ted Strickland committee member S001004
CHRG-108hhrg96099,Thomas H. Allen FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Thomas H. Allen committee member A000147
CHRG-108hhrg96099,Vito Fossella FDA'S ROLE IN PROTECTING THE PUBLIC HEALTH: EXAMINING FDA'S REVIEW OF SAFETY AND EFFICACY CONCERNS IN ANTI-DEPRESSANT USE BY CHILDREN CHRG-108hhrg96099 Vito Fossella committee member F000440

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE hearing_members (
    package_id TEXT NOT NULL REFERENCES hearings(package_id),
    name TEXT NOT NULL,
    role TEXT,
    bioguide_id TEXT,
    PRIMARY KEY (package_id, name)
);
CREATE INDEX idx_hm_name ON hearing_members(name);
CREATE INDEX idx_hm_bioguide ON hearing_members(bioguide_id);